The Global Healthy Living Foundation (GHLF) is a 501 (c)(3) patient group that works to
improve the quality of life for people with chronic disease, often focusing on those least able to advocate for themselves.
Good morning Mr. Chairman and committee members.
My name is Rachelle. I’m a patient advocate and member of the Global Healthy Living Foundation’s 50-State Network. I have been a resident of Chesterfield, Michigan for the past 12 years, but I am a lifelong Michigander. My legislators are Representative Andrea LaFontaine and Senator Jack Brandenburg. I want to thank you for allowing me to speak today about House Bill 4812.
The existence of CT-P13, a biosimilar version of infliximab (Remsima), and its recommended approval on Tuesday by the FDA Arthritis Advisory Committee, is reason to celebrate.
Salem resident Joni Johnston testified to the Missouri General Assembly’s House Emerging Issues Committee Jan. 20.
The committee will discuss biologics license application (BLA) 125544, for CT-P13, a
proposed biosimilar to Janssen Biotech Inc.’s REMICADE (infliximab), submitted by Celltrion,